Senate committee refers kratom consumer‑safety bill for amendment after split testimony on safety, testing and enforcement

Senator Nichols presented S 1418, the Idaho Kratom Consumer Protection and Safety Act, telling the committee the bill would set safety standards that limit 7‑hydroxymitragynine (7‑OH) to no more than 2 percent or 1 milligram per serving, require labeling and restrict sales to adults 21 and older. She said the bill reflected input from law enforcement, clinicians and industry.

Multiple witnesses testified against the bill, including physicians, family members of overdose victims and law‑enforcement representatives who urged a full ban or argued kratom is addictive and unsafe. Chief Tracy Basterrechea of the Idaho Chiefs of Police Association said law enforcement currently lacks the equipment to differentiate natural kratom from synthetic 7‑OH and estimated testing equipment costs at about $350,000 one‑time plus $35,000 annually.

Supporters — including toxicologists, clinicians and industry groups such as the American Kratom Association — described people using kratom for pain management or as part of recovery and warned a total ban could push users to illicit opioids. Professor Marilyn Huestis and others described research suggesting natural kratom has tolerability and that reported overdoses could involve incomplete toxicology.

Senator Nichols closed by saying the bill creates a balanced regulatory framework and argued that "kratom should be regulated in the same way alcohol and tobacco were regulated." After debate about labeling and enforcement roles for the Idaho State Police, Senator Keyser moved to send S 1418 to the 14th Order of Business for possible amendment; Senator Wintrow seconded and the motion carried by voice vote with Senators Harris, Blaylock and Chair VanOrden recorded as voting nay.

The committee will consider amendments addressing testing, labeling and ISP responsibilities before further action.